---
title: "Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294747789.md"
description: "Halper Sadeh LLC is investigating Arcosa, Crinetics Pharmaceuticals, and Leggett & Platt for potential breaches of fiduciary duties regarding their proposed acquisitions. The firm questions if shareholders are receiving fair deals in transactions involving CRH, Vertex Pharmaceuticals, and Somnigroup International, respectively. Shareholders are encouraged to contact the firm to discuss their legal rights and options on a contingent fee basis."
datetime: "2026-08-03T23:39:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294747789.md)
  - [en](https://longbridge.com/en/news/294747789.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294747789.md)
generator: "portal-rs"
---

# Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.***

***The proposed transactions may contain terms that could limit superior competing offers.***

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.***

NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

**Arcosa, Inc. ()'s** sale to CRH for $150.00 per share. **If you are an Arcosa shareholder,** **click here to learn more about your rights and options****.**

**Crinetics Pharmaceuticals, Inc. ()'s** sale to Vertex Pharmaceuticals Incorporated for $85.00 per share in cash. **If you are a Crinetics shareholder,** **click here to learn more about your legal rights and options**.

**Leggett & Platt, Incorporated ()'s** sale to Somnigroup International Inc. for 0.1455 shares of Somnigroup common stock for each share of Leggett & Platt common stock. Upon closing of the proposed transaction, Leggett & Platt shareholders will own approximately 9% of the combined company. **If you are a Leggett & Platt shareholder,** **click here to learn more about your legal rights and options**.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

### Related Stocks

- [LEG.US](https://longbridge.com/en/quote/LEG.US.md)
- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [ACA.US](https://longbridge.com/en/quote/ACA.US.md)
- [CRH.US](https://longbridge.com/en/quote/CRH.US.md)
- [SGI.US](https://longbridge.com/en/quote/SGI.US.md)
- [CRH.UK](https://longbridge.com/en/quote/CRH.UK.md)

## Related News & Research

- [Bank of America Corp DE Sells 85,189 Shares of Crinetics Pharmaceuticals, Inc. $CRNX](https://longbridge.com/en/news/296069006.md)
- [TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296021261.md)
- [Are Wall Street Analysts Bullish on Vertex Stock?](https://longbridge.com/en/news/296449653.md)
- [Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/296161669.md)
- [Crinetics supplements proxy disclosures for Vertex USD 85-per-share buyout after shareholder suits](https://longbridge.com/en/news/296395094.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**